Role of carbon-11 choline PET/CT in the management of uterine carcinoma: Initial experience

Annals of Nuclear Medicine

Volumn 23, Issue 3, 2009, Pages 235-243

  Sofue, Keitaro ^a   Tateishi, Ukihide ^b   Sawada, Morio ^a   Maeda, Tetsuo ^c   Terauchi, Takashi ^d   Kano, Daisuke ^d   Arai, Yasuaki ^a   Inoue, Tomio ^b   Sugimura, Kazuro ^c  

^a NATIONAL CANCER CENTER HOSPITAL   (Japan)

^b YOKOHAMA CITY UNIVERSITY GRADUATE SCHOOL OF MEDICINE   (Japan)

^c KOBE UNIVERSITY GRADUATE SCHOOL OF MEDICINE   (Japan)

^d NATIONAL CANCER CENTER   (Japan)

Author keywords

Choline; PET CT; Uterine

Indexed keywords

CHOLINE C11; CISPLATIN; RADIOPHARMACEUTICAL AGENT; UNCLASSIFIED DRUG;

ADOLESCENT; ADULT; AGED; ARTICLE; CANCER CHEMOTHERAPY; CANCER DIAGNOSIS; CANCER RADIOTHERAPY; CANCER STAGING; CLINICAL ARTICLE; CLINICAL EVALUATION; COMPUTER ASSISTED EMISSION TOMOGRAPHY; CONTROLLED STUDY; DIAGNOSTIC ACCURACY; DRUG UPTAKE; FEMALE; FOLLOW UP; HISTOPATHOLOGY; HUMAN; HUMAN TISSUE; MEDICAL SPECIALIST; NUCLEAR MAGNETIC RESONANCE IMAGING; NUCLEAR MEDICINE; PELVIS; POSITRON EMISSION TOMOGRAPHY; PRIORITY JOURNAL; RADIOLOGIST; RETROSPECTIVE STUDY; STANDARDIZED UPTAKE VALUE; TUMOR VOLUME; UTERINE CERVIX CARCINOMA; UTERUS CARCINOMA; VOLUMETRY;

ADULT; AGED; CARBON RADIOISOTOPES; CHOLINE; FEMALE; HUMANS; MAGNETIC RESONANCE IMAGING; MIDDLE AGED; NEOPLASM STAGING; POSITRON-EMISSION TOMOGRAPHY; RETROSPECTIVE STUDIES; SENSITIVITY AND SPECIFICITY; TOMOGRAPHY, X-RAY COMPUTED; UTERINE NEOPLASMS;

EID: 67349244271     PISSN: 09147187     EISSN: None     Source Type: Journal    
DOI: 10.1007/s12149-009-0230-z     Document Type: Article

References (25)

1. 11C]choline J Nucl Med 38 842 847 (Pubitemid 27251970)
2. T Hara N Kosaka H Kishi 1998 PET imaging of prostate cancer using carbon-11-choline J Nucl Med 39 990 995 (Pubitemid 28270113)
3. PL Jager TH Que W Vaalburg J Prium P Elsinga JT Plukker 2001 Carbon-11 choline or FDG-PET for staging of oesophageal cancer? Eur J Nucl Med 28 1845 1849 (Pubitemid 33141252)
4. RM Pieterman TH Que PH Elsinga J Pruim JW van Putten AT Willemsen 2002 (11)C-choline and (18)F-FDG PET in primary diagnosis and staging of patients with thoracic cancer J Nucl Med 43 167 172
5. IJ de Jong J Prium PH Elsinga W Vaalburg HJ Mensink 2003 Preoperative staging of pelvic lymph nodes in prostate cancer by 11C-choline PET J Nucl Med 44 331 335 (Pubitemid 39586006)
6. M Picchio U Treiber AJ Beer S Metz P Bossner H van Randenborgh 2006 Value of 11C-choline PET and contrast-enhanced CT for staging of bladder cancer: correlation with histopathologic findings J Nucl Med 47 938 944 (Pubitemid 46939945)
7. 11C-choline PET and FDG PET for the differential diagnosis of malignant tumors Eur J Nucl Med Mol Imaging 31 1064 1072 (Pubitemid 39050172)
8. B Scher M Seitz W Albinger R Tiling M Scherr HC Becker 2007 Value of (11)C-choline PET and PET/CT in patients with suspected prostate cancer Eur J Nucl Med Mol Imaging 34 45 53
9. 18F-FDG PET J Nucl Med 44 1051 1056 (Pubitemid 39663379)
10. P Therasse SG Arbuck EA Eisenhauer J Wanders RS Kaplan L Rubinstein 2000 New guidelines to evaluate the response to treatment in solid tumors. European Organization for Research and Treatment of Cancer, National Cancer Institute of the United States, National Cancer Institute of Canada J Natl Cancer Inst 92 205 216
11. H Young R Baum U Cremerius K Herholz O Hoekstra AA Lammertsma 1999 Measurement of clinical and subclinical tumour response using [18F]-fluorodeoxyglucose and positron emission tomography: review and 1999 EORTC recommendations. European Organization for Research and Treatment of Cancer (EORTC) PET Study Group Eur J Cancer 35 1773 1782
12. Y Nakamoto A Eisbruch ED Achtyes Y Sugawara KR Reynolds CM Johnston 2002 Prognostic value of positron emission tomography using F-18-fluorodeoxyglucose in patients with cervical cancer undergoing radiotherapy Gynecol Oncol 84 289 295 (Pubitemid 34136782)
13. PW Grigsby BA Siegel F Dehdashti J Rader I Zoberi 2004 Posttherapy [18F] fluorodeoxyglucose positron emission tomography in carcinoma of the cervix: response and outcome J Clin Oncol 22 2167 2171 (Pubitemid 41095151)
14. Y Yoshida T Kurokawa K Kawahara A Yagihara T Tsuchida H Okazawa 2004 Metabolic monitoring of advanced uterine cervical cancer neoadjuvant chemotherapy by using [F-18]-Fluorodeoxyglucose positron emission tomography: preliminary results in three patients Gynecol Oncol 95 597 602 (Pubitemid 39592527)
15. F Xue LL Lin F Dehdashti TR Miller BA Siegel PW Grigsby 2006 F-18 fluorodeoxyglucose uptake in primary cervical cancer as an indicator of prognosis after radiation therapy Gynecol Oncol 101 147 151 (Pubitemid 43303575)
16. R Bar-Shalom N Yefremov L Guralnik D Gaitini A Frenkel A Kuten 2003 Clinical performance of PET/CT in evaluation of cancer: additional value for diagnostic imaging and patient management J Nucl Med 44 1200 1209 (Pubitemid 39655178)
17. 11C]choline, a positron-emitting tracer for tumor imaging Appl Radiat Isot 50 531 533 (Pubitemid 29067609)
18. Sobin LH, Wittekind C. UICC TNM classification of malignant tumours. 6th ed. New York: Wiley; 2002.
19. JL Benedet H Bender H Jones III HY Ngan S Pecorelli 2000 FIGO staging classifications and clinical practice guidelines in the management of gynecologic cancers. FIGO Committee on Gynecologic Oncology Int J Gynaecol Obstet 70 209 262
20. K Togashi K Nishimura T Sagoh S Minami S Noma I Fujisawa 1989 Carcinoma of the cervix: staging with MR imaging Radiology 171 245 251 (Pubitemid 19093078)
21. R Manfredi P Mirk G Maresca PA Margariti A Testa GF Zannoni 2004 Local-regional staging of endometrial carcinoma: role of MR imaging in surgical planning Radiology 231 372 378 (Pubitemid 38552891)
22. PW Grigsby BA Siegel F Dehdashti 2001 Lymph node staging by positron emission tomography in patients with carcinoma of the cervix J Clin Oncol 19 3745 3749 (Pubitemid 32844787)
23. S Sironi A Buda M Picchio P Perego R Moreni A Pelleqrino 2006 Lymph node metastasis in patients with clinical early-stage cervical cancer: detection with integrated FDG PET/CT Radiology 238 272 279 (Pubitemid 43010605)
24. M Heinisch A Dirisamer W Loidl F Stoiber B Gruy S Haim 2006 Positron emission tomography/computed tomography with F-18-fluorocholine for restaging of prostate cancer patients: meaningful at PSA <5 ng/ml? Mol Imaging Biol 8 43 48 (Pubitemid 44193401)
25. F Gutman V Aflalo-Hazan K Kerrou F Montravers D Grahek JN Talbot 2006 18F-choline PET/CT for initial staging of advanced prostate cancer AJR Am J Roentogenol 187 618 621